
Live Take-Two Interactive Software, Inc. Common Stock (Derivatives) price
Take-Two Interactive Software, Inc. Common Stock (Derivatives) price chart
Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO) price details

Take-Two Interactive Software, Inc. Common Stock (Derivatives) price history
Take-Two Interactive Software, Inc. Common Stock (Derivatives) technical analysis

Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO) sentiment
About Take-Two Interactive Software, Inc. Common Stock (Derivatives)
Official links
Social media and community
FAQ
1. What is the current price of Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO) in USD?
2. What is the market capitalization of Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
3. What is the circulating supply of Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
4. What factors influence the price of Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
5. Is Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO) a good investment?
6. Where can I buy Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
7. What are the typical fees when buying Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
8. What are some technical indicators used for analyzing Take-Two Interactive Software, Inc. Common Stock (Derivatives) (TTWO)?
Currency price converter
Popular
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Take-Two Interactive Software, Inc. Common Stock (Derivatives) news
Trump Faces Criticism Over Possible Transfer of Yosemite Land to Private Developer
An investigation indicates that the Donald Trump administration is considering transferring a strip of approximately 400 meters of Yosemite National Park to a company linked to Kingsbarn Realty Capital, in exchange for another yet-to-be-defined piece of land.
Rasonque Could Become a Blockbuster After Revolutionizing Pancreatic Cancer Treatment
Rasonque, the new treatment from Revolution Medicines for certain patients with pancreatic cancer, has received accelerated approval and could become one of the most lucrative oncology launches in history.
[Energy Analysis] The Next Bottleneck for AI Is Not GPUs... It's the Power Grid
Artificial Intelligence (AI) has begun to consume not only the world's semiconductors but also the power grid. For the past few years, the question in the AI infrastructure competition has been simple: Who can secure more GPUs?
This Week's Highlights: AI Resurgence, Fed's Hawkish Stance Shakes Markets, US-Iran Tensions Escalate
[Energy Analysis] China’s Solar Power Dominates the World Yet Faces Deficits... The 'Paradox of Overproduction' Emerges
Chinese manufacturers, who dominate the global solar market, find themselves paradoxically unable to make profits. Leading Chinese solar companies JinkoSolar, JA Solar, and Tongwei all recorded significant losses in the first half of this year.
Central Bank Digital Currency on the Blockchain: European Central Bank Takes the Lead
The European Central Bank (ECB) has proposed using central bank digital currency (CBDC) as a settlement asset within the tokenized financial market. The ECB believes that CBDCs can provide greater stability for wholesale financial settlements compared to private stablecoins.












